From October 29, 2014 to October 31, 2014, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on October 29, 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.15 USD | -2.17% |
|
+34.04% | -18.81% |
07-17 | Anixa Biosciences Receives Patent for Breast Cancer Vaccine Technology in Japan | MT |
07-17 | Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.81% | 103M | |
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- ANIX Stock
- News Anixa Biosciences, Inc.
- Tranche Update on ITUS Corporation's Equity Buyback Plan announced on October 29, 2014.